Skip to content

Efficacy and Safety Evaluation of Liuteng Anji Decoction Combined with Salicylazosulfapyridine in theTreatment of Active Ankylosing Spondylitis

Efficacy and Safety Evaluation of Liuteng Anji Decoction Combined with Salicylazosulfapyridine in theTreatment of Active Ankylosing Spondylitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055901
Enrollment
Unknown
Registered
2022-01-23
Start date
2020-12-01
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing Spondylitis

Interventions

Observation Group:Liutenganji decoction+SASP treatment
Control Group:Simulated Chinese medicine soup+ SASP treatment

Sponsors

Yancheng Hospital of Traditional Chinese Medicine, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic and typing criteria of traditional Chinese and Western medicine; 2. Aged 16 to 55 years; 3. Voluntary participation and signing of informed consent; 4. The disease is in the active stage (BASDAI >= 6 or BASDAI >= 4 with either of increase in CRP or ESR).

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation; 2. Severe primary diseases such as liver, kidney, heart, and cerebrovascular diseases and psychosis were complicated; 3. Late severe joint deformity and disability; 4. Combined with other rheumatic diseases; 5. Use NSAIDs <= 2 weeks, or use slow medication <= 1 month, or use biological agents <= 3 months.

Design outcomes

Primary

MeasureTime frame
Spinal pain, nocturnal pain and patient global assessment (PGA) score;Reference requirements for evaluation of disease activity index (BASDAI), functional index (BASFI), measurement index (BASMI) and AS patient sum index (BAS-G);Reference requirements for occipital-wall distance, fingertip-ground distance, thoracic range of motion, spinal range of motion, schober test evaluation;C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR);TCM syndrome score;assessment in ankylosing Spondylitis, ASAS;Adverse reaction;

Countries

China

Contacts

Public ContactLi Rongliang

Yancheng Hospital of Traditional Chinese Medicine, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine

lipeter@163.com+86 13815582097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026